EUVIMEDOpdag EUVIMED
Crossref

Oncogenic Peptide Encoded by Noncoding RNA of FOXM1 Promotes Pancreatic Cancer Malignancy Through PI3K/AKT Signaling

Xinyan Huang, Jie He, Qihui Sun, Liuxi Zhang, Yuxi Niu, Tian Cai, Bo Ling, Tingting Jiang, Xiaojia Li, Keping Xie

Molecular Carcinogenesis · 2026

DOI: 10.1002/mc.70051 ↗

At a glance

Journal article in Molecular Carcinogenesis, 2026. Written by Xinyan Huang and 9 co-authors. Institution: Center for Pancreatic Cancer Research, The South China University of Technology School of Medicine, Guangzhou, Guangdong, China. Major MEDLINE topics: Pancreatic Neoplasms, Forkhead Box Protein M1, Proto-Oncogene Proteins c-akt, Phosphatidylinositol 3-Kinases. 51 references. Funded by: This research was supported by National Natural Science Foundation of China and Guangzhou Municipality Bureau of Science and Technology., National Natural Science Foundation of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Alternative splicing of FOXM1 produces different isoforms, which have been proven to exist and have complex functions. One of the isoforms of FOXM1, isoform ENST00000535350, is a short noncoding RNA sequence, designated as FOXM1s here. We determined the function and mechanism of FOXM1s‐encoded peptide, FOXM1s, in the development and progression of pancreatic cancer. The expression of FOXM1s as noncoding RNA in pancreatic cancer tissues and cell lines was analyzed by RT‐PCR. Gene expression and its association with clinicopathologic characteristics of patients with PDAC were analyzed using IF and bioinformatics. The effects on cell proliferation, migration, invasion, tumor stemness, and on PI3K/AKT signaling were evaluated through in vitro biology methods and functionally validated in mouse models by using overexpression and knockdown approaches. The expression of FOXM1s in human pancreatic cancer tissues and cell lines was significantly increased. The overexpression of FOXM1s had a promoting effect on pancreatic cancer, while the mutation of FOXM1s attenuated its effect, indicating that FOXM1s exerted its role potentially through ORF2‐encoded a peptide. The specific antibody #FOXM1s was used to validate that FOXM1s expressed a predicted peptide, FOXM1s, and its expression was upregulated in pancreatic cancer. FOXM1s significantly promoted the proliferation, migration, and invasion of pancreatic cancer cells, facilitated liver metastasis, and upregulated the expression of stem‐related genes in pancreatic cancer. Mechanistically, the FOXM1s peptide encoded by FOXM1s activated the PI3K/AKT signaling pathway. FOXM1s encodes a FOXM1s peptide and exhibits oncogenic function in the pancreatic cancer development progression at least in part through activating PI3K/AKT signaling pathway. This novel molecule could serve as a potential therapeutic target.

Subjects

MeSH terms (MEDLINE)

Pancreatic NeoplasmsForkhead Box Protein M1Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-KinasesPeptidesRNA, UntranslatedHumansAnimalsMiceSignal TransductionCell ProliferationGene Expression Regulation, NeoplasticCell MovementCell Line, TumorMaleFemaleMiddle Aged

Author keywords

FOXM1 FOXM1sNoncoding RNAisoformspancreatic cancerpeptidetumor stemnes

Substances

Forkhead Box Protein M1Proto-Oncogene Proteins c-aktFOXM1 protein, humanPhosphatidylinositol 3-KinasesPeptidesRNA, Untranslated

Authors and institutions

  • Center for Pancreatic Cancer Research, The South China University of Technology School of Medicine, Guangzhou, Guangdong, China.
  • Departments of Pathology and Immunology, The South China University of Technology School of Medicine, Guangzhou, Guangdong, China.
  • Department of Laboratory Medicine, The First People's Hospital of Foshan, Foshan, Guangdong, China.
  • College of Pharmacy, Youjiang Medical University for Nationalities, Baise, Guangxi, China.

Funding

  • This research was supported by National Natural Science Foundation of China and Guangzhou Municipality Bureau of Science and Technology.
  • National Natural Science Foundation of China

Cite

APA

Huang, X., He, J., Sun, Q., Zhang, L., Niu, Y., Cai, T., Ling, B., Jiang, T., Li, X., & Xie, K. (2026). Oncogenic Peptide Encoded by Noncoding RNA of FOXM1 Promotes Pancreatic Cancer Malignancy Through PI3K/AKT Signaling. Molecular Carcinogenesis. https://doi.org/10.1002/mc.70051

Vancouver

Huang X, He J, Sun Q, Zhang L, Niu Y, Cai T, et al. Oncogenic Peptide Encoded by Noncoding RNA of FOXM1 Promotes Pancreatic Cancer Malignancy Through PI3K/AKT Signaling. Molecular Carcinogenesis. 2026. doi:10.1002/mc.70051

BibTeX
@article{Huang2026,
  author = {Huang, Xinyan and He, Jie and Sun, Qihui and Zhang, Liuxi and Niu, Yuxi and Cai, Tian and Ling, Bo and Jiang, Tingting and Li, Xiaojia and Xie, Keping},
  title = {Oncogenic Peptide Encoded by Noncoding RNA of FOXM1 Promotes Pancreatic Cancer Malignancy Through PI3K/AKT Signaling},
  journal = {Molecular Carcinogenesis},
  year = {2026},
  doi = {10.1002/mc.70051}
}
Start for free →